1.15
Werewolf Therapeutics Inc Borsa (HOWL) Ultime notizie
Werewolf Therapeutics Inc. stock trend forecastWall Street Watch & Accurate Entry/Exit Alerts - newser.com
FY2025 Earnings Estimate for HOWL Issued By Leerink Partnrs - Defense World
Wedbush Expects Increased Earnings for Werewolf Therapeutics - Defense World
Werewolf Therapeutics Presents Data Expanding Its PREDATOR® Platform at the Society for ... - Bluefield Daily Telegraph
Werewolf Therapeutics Presents Data Expanding Its PREDATOR® Platform at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting - Stock Titan
Mpm Bioventures sells Werewolf Therapeutics (HOWL) stock for $295k By Investing.com - Investing.com South Africa
Werewolf Therapeutics: Multiple 10% owners sell $295k in shares By Investing.com - Investing.com Philippines
Mpm Bioventures sells Werewolf Therapeutics (HOWL) stock for $295k - Investing.com India
Werewolf Therapeutics: Multiple 10% owners sell $295k in shares - Investing.com India
Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $189,830 - Investing.com India
Evnin Luke sells Werewolf Therapeutics (HOWL) stock for $189,830 By Investing.com - Investing.com Canada
[Form 4] Werewolf Therapeutics, Inc. Insider Trading Activity - Stock Titan
Werewolf Therapeutics Faces Nasdaq Compliance Challenge - MSN
How Werewolf Therapeutics Inc. stock performs after earningsJuly 2025 WrapUp & Verified Chart Pattern Signals - newser.com
Visual trend scoring systems applied to Werewolf Therapeutics Inc.July 2025 PostEarnings & Safe Entry Trade Reports - newser.com
Is Werewolf Therapeutics Inc. stock bottoming out2025 Biggest Moves & Safe Swing Trade Setups - newser.com
Predicting Werewolf Therapeutics Inc. trend using moving averagesQuarterly Trade Report & Technical Entry and Exit Tips - newser.com
Will Werewolf Therapeutics Inc. price bounce be sustainableMarket Performance Recap & Community Consensus Stock Picks - newser.com
Will Werewolf Therapeutics Inc. stock outperform growth indexes2025 Earnings Impact & AI Enhanced Trading Signals - newser.com
How to read the order book for Werewolf Therapeutics Inc.Analyst Upgrade & Technical Pattern Based Signals - newser.com
Analyzing recovery setups for Werewolf Therapeutics Inc. investors2025 Price Action Summary & Safe Entry Zone Tips - newser.com
Advanced analytics toolkit walkthrough for Werewolf Therapeutics Inc.Weekly Investment Report & AI Based Buy and Sell Signals - newser.com
Will Werewolf Therapeutics Inc. stock recover faster than market2025 Market Outlook & Risk Managed Investment Signals - newser.com
Wedbush Halves Price Target on Werewolf Therapeutics to $3 From $6, Keeps Outperform Rating - MarketScreener
Werewolf Therapeutics Narrows Losses And Wins FDA Fast Track Nod - Finimize
Why Werewolf Therapeutics Inc. stock is rated strong buyTake Profit & Safe Capital Growth Stock Tips - fcp.pa.gov.br
Identifying reversal signals in Werewolf Therapeutics Inc.July 2025 Momentum & Consistent Profit Alerts - newser.com
What MACD signals say about Werewolf Therapeutics Inc.2025 Price Action Summary & Low Risk Entry Point Tips - newser.com
Werewolf Therapeutics Reports Q3 2025 Financial Results - TipRanks
Luke Evnin Sells 55,795 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock - MarketBeat
Werewolf Therapeutics (NASDAQ:HOWL) Director Luke Evnin Sells 60,369 Shares - MarketBeat
Bioventures 2014 L.P. Mpm Sells 86,936 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock - MarketBeat
Insider Selling: Werewolf Therapeutics (NASDAQ:HOWL) Major Shareholder Sells 114,044 Shares of Stock - MarketBeat
Ansbert Gadicke Sells 86,936 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock - MarketBeat
Werewolf Therapeutics (NASDAQ:HOWL) Major Shareholder Ansbert Gadicke Sells 114,044 Shares - MarketBeat
Insider Selling: Werewolf Therapeutics (NASDAQ:HOWL) Major Shareholder Sells 94,063 Shares of Stock - MarketBeat
Werewolf Therapeutics (NASDAQ:HOWL) Major Shareholder Sells $121,341.27 in Stock - MarketBeat
Werewolf Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Werewolf Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update - Investing News Network
Werewolf Therapeutics Q3 net loss narrows on lower R&D expenses - MarketScreener
[8-K] Werewolf Therapeutics, Inc. Reports Material Event | HOWL SEC FilingForm 8-K - Stock Titan
Werewolf Therapeutics (NASDAQ: HOWL) says cash funds operations into Q4 2026 - Stock Titan
Is Werewolf Therapeutics Inc. reversing from oversold territory2025 Top Decliners & Proven Capital Preservation Methods - newser.com
Werewolf therapeutics director Evnin sells $251k in HOWL stock - Investing.com India
Werewolf therapeutics director Evnin sells $251k in HOWL stock By Investing.com - Investing.com Australia
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):